Desafios da rinoplastia cirúrgica em nariz previamente preenchido com ácido hialurônico
##plugins.themes.bootstrap3.article.sidebar##
Publicado
May 9, 2023
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Avaliar as complicações advindas da aplicação de ácido hialurônico nos procedimentos de rinomodelação e como a presença desse preenchedor impacta as ações em uma futura intervenção de rinoplastia cirúrgica e os cuidados que o cirurgião deve ter durante seu procedimento. Revisão bibliográfica: Granuloma é um evento adverso importante, tardio e raro. Necrose cutânea é uma das complicações precoces mais graves e temidas. Eventos vasculares podem resultar sequelas permanentes. Dissecção de nariz com presença de preenchimento residual poderá gerar dificuldades no procedimento. As ações realizadas poderão sofrer modificações com o tempo alterando o resultado final. Deve-se avaliar o que foi previamente injetado, a camada de aplicação e considerar a possibilidade de presença de tecido fibrocicatricial. Considerações finais: Cirurgião deverá verificar a ocorrência de interversões prévias como preenchedores. Poderá utilizar ultrassom e ou transluminescência para deteção de localidade, volume, fibrozamento tecidual e outros fatores que possam prejudicar o resultado final.
##plugins.themes.bootstrap3.article.details##
Como Citar
CostaV. N. da. (2023). Desafios da rinoplastia cirúrgica em nariz previamente preenchido com ácido hialurônico. Revista Eletrônica Acervo Saúde, 23(5), e12064. https://doi.org/10.25248/reas.e12064.2023
Seção
Revisão Bibliográfica
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. BARDOT J, et al. Rhinoplastie standard de réduction [Standard rhinoplasty], French. Ann Chir Plast Esthet. 2014; 59(6): 424-428, 2014.
2. BERTOSSI D, et al. Complications and management after a nonsurgical rhinoplasty: a literature review. Dermatologic Therapy, 2019; 32(4): e12978, 2019.
3. BERTOSSI D, et al. Nonsurgical rhinoplasty with the novel hyaluronic acid filler VYC-25L: results using a nasal grid approach. Aesthet Surg J, 2021; 41(6): NP512-NP520, 2021.
4. BORZABADI-FARAHANI A, et al. A Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic Interventions. Aesth Plast Surg (2022).
5. BUHREN BA, et al. Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res, 2016; 21: 5.
6. CARRUTHERS JDA, et al. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg, 2014; 134(6): 1197-1201.
7. CAVALLIERI FA. Advantages of sonography in fillers and complications. In: Bard RL (ed) Image Guided Dermatologic Treatments. Springer International Publishing, Cham, 2020: 93–101.
8. DELORENZI C. Complication of injectable fillers, part 2; vascular complication. Aesthet Surg J, 2014; 34(4): 584-600.
9. DELORENZI C. New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events. Aesthet Surg J, 2017; 37(7): 814-825.
10. DEY JK, et al. 3RD. Assessing nasal soft-tissue envelope thickness for rhinoplasty: normative data and a predictive algorithm. JAMA Facial Plast Surg, 2019; 21(6): 511–517.
11. DU S, et al. Compound facial expressions of emotion. Proc. Natl. Acad. Sci. USA, 2014; 111(15): E1454‐1462.
12. FALLACARA A, et al. Hyaluronic acid in the third millennium. Polymers (Basel). 2018; 10(7): 701.
13. FAIVRE J, et al. Crosslinking hyaluronic acid soft-tissue fillers: current status and perspectives from an industrial point of view, Expert Review of Medical Devices, 2021; 18(12): 1175-1187.
14. FICHMAN M, et al. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430685/
15. FILIPPOVA OV, et al. Clinical and morphological characteristics of the vascular bed of hypertrophic scar tissue in different periods of its formation. Pediatr Traumatol Orthop Reconstr Surg, 2017; 5(3): 25-35.
16. FRIEDMANN DP, et al. Delayed granulomatous reactions to facial cosmetic injections of polymethylmethacrylate microspheres and liquid injectable silicone: a case series. J cosmet laser Ther: Off Publ Eur Soc Laser Dermatol, 2016; 18(3): 170–173.
17. GOODMAN GJ e CLAGUE MD A Rethink on Hyaluronidase Injection, Intraarterial Injection, and Blindness: Is There Another Option for Treatment of Retinal Artery Embolism Caused by Intraarterial Injection of Hyaluronic Acid? Dermatol Surg, 2016; 42(4): 547-549.
18. HIRSCH RJ, et al. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg, 2007; 33: 357–360.
19. IBÁÑEZ-BERGANZA M, et al. Subjectivity and complexity of facial attractiveness. Sci Rep, 2019; 9: 8364.
20. JANG JW e KANG SY. Evaluation and management of facial granuloma caused by various injection materials. Arch Craniofac Surg, 2021; 22(1): 26-32.
21. JONES DH, et al. Preventing and Treating Adverse Events of Injectable Fillers: Evidence-Based Recommendations From the American Society for Dermatologic Surgery Multidisciplinary Task Force. Dermatol Surg, 2021; 47(2): 214-226.
22. KIM ZH, et al. A composite dermal filler comprising cross-linked hyaluronic acid and human collagen for tissue reconstruction. J Microbiol Biotechnol, 2015; 25(3): 399–406.
23. KURKJIAN TJ, et al. Soft-tissue fillers in rhinoplasty. Plast Reconstr Surg, 2014; 133(2): 121e-6e.
24. MCCRAKEN MS, et al. Hyaluronic acid gel (Restylane) filler for facial rhytides: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr Surg, 2006; 22(3): 188-191.
25. MOON HJ. Injection Rhinoplasty Using Filler. Facial Plast Surg Clin NorthAm, 2018; 26(3): 323-330.
26. MOON HJ. Use of Fillers in Rhinoplasty. Clin Plast Surg, 2016; 43(1): 307-317.
27. NEVES JC, et al. Rhinoplasty Dissection Planes (Subcutaneous, Sub-SMAS, Supra-perichondral, and Sub-perichondral) and Soft Tissues Management. Facial Plast Surg, 2021; 37(1): 2-11.
28. PARADA MB, et al. Fillers: Complications and Their Management. In: Issa, M., Tamura, B. (eds) Botulinum Toxins, Fillers and Related Substances. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, 2019, vol 4; 443p.
29. RAMOS HHA, et al. Hyaluronic acid filler in the treatment for drooping tip: anatomical concepts and clinical results. Aesthet Plast Surg, 2020; 44(6): 2173-2182.
30. RAMOS HHA, et al. Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic Acid. Aesthetic Plast Surg, 2021; 45(4): 1675-1682.
31. ROSEMAN CC e WEAVER TD. Multivariate apportionment of global human craniometric diversity. Am J Phys Anthropol, 2004; 125(3): 257–263.
32. ROSENBERGER ES e TORIUMI DM. Controversies in Revision Rhinoplasty. Facial Plast Surg Clin North Am, 2016; 24(3): 337-345.
33. ROUANET C, et al. Management of vascular complications following facial hyaluronic acid injection: high-dose hyaluronidase protocol: a technical note. J Stomatol Oral Maxillofac Surg, 2022; 123(2): 262–265.
34. SALINAS-ALVAREZ Y, et al. Hyaluronic Acid Embolism Treated with Subcutaneous High and Low Hyaluronidase Doses: Efficacy and Surrounding Tissue Effect. Plast Reconstr Surg, 2021;148(6):1281-1288.
35. SCIABICA S, et al. Design, Synthesis, Characterization, and In Vitro Evaluation of a New Cross-Linked Hyaluronic Acid for Pharmaceutical and Cosmetic Applications. Pharmaceutics. 2021; 13(10): 1672.
36. SITO G, et al. Vascular Complications after Facial Filler Injection: A Literature Review and Meta-analysis. J Clin Aesthet Dermatol, 2019; 12(6): E65-E72.
37. STAGLIANÒ S, et al. An Italian Online Survey Regarding the Use of Hyaluronidase in Previously Hyaluronic Acid-Injected Noses Looking for Surgical Rhinoplasty. Aesthet Surg J Open Forum, 2022; 4: ojac060.
38. THOMAS M e D’SILVA J. Nonsurgical Rhinoplasty. In: Keyhan SO, et al. Integrated Procedures in Facial Cosmetic Surgery. Springer, Cham. 2021; 235-248.
39. von BAHR G. Multiple embolisms in the fundus of an eye after an injection in the scalp. Acta Ophthalmol (Copenh), 1963; 41(1): 85-91.
40. WILKINS A. Making Faces: The Evolutionary Origins of the Human Face. The Belknap Press of Harvard University Press; 2017; 472p.
2. BERTOSSI D, et al. Complications and management after a nonsurgical rhinoplasty: a literature review. Dermatologic Therapy, 2019; 32(4): e12978, 2019.
3. BERTOSSI D, et al. Nonsurgical rhinoplasty with the novel hyaluronic acid filler VYC-25L: results using a nasal grid approach. Aesthet Surg J, 2021; 41(6): NP512-NP520, 2021.
4. BORZABADI-FARAHANI A, et al. A Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic Interventions. Aesth Plast Surg (2022).
5. BUHREN BA, et al. Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res, 2016; 21: 5.
6. CARRUTHERS JDA, et al. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg, 2014; 134(6): 1197-1201.
7. CAVALLIERI FA. Advantages of sonography in fillers and complications. In: Bard RL (ed) Image Guided Dermatologic Treatments. Springer International Publishing, Cham, 2020: 93–101.
8. DELORENZI C. Complication of injectable fillers, part 2; vascular complication. Aesthet Surg J, 2014; 34(4): 584-600.
9. DELORENZI C. New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events. Aesthet Surg J, 2017; 37(7): 814-825.
10. DEY JK, et al. 3RD. Assessing nasal soft-tissue envelope thickness for rhinoplasty: normative data and a predictive algorithm. JAMA Facial Plast Surg, 2019; 21(6): 511–517.
11. DU S, et al. Compound facial expressions of emotion. Proc. Natl. Acad. Sci. USA, 2014; 111(15): E1454‐1462.
12. FALLACARA A, et al. Hyaluronic acid in the third millennium. Polymers (Basel). 2018; 10(7): 701.
13. FAIVRE J, et al. Crosslinking hyaluronic acid soft-tissue fillers: current status and perspectives from an industrial point of view, Expert Review of Medical Devices, 2021; 18(12): 1175-1187.
14. FICHMAN M, et al. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430685/
15. FILIPPOVA OV, et al. Clinical and morphological characteristics of the vascular bed of hypertrophic scar tissue in different periods of its formation. Pediatr Traumatol Orthop Reconstr Surg, 2017; 5(3): 25-35.
16. FRIEDMANN DP, et al. Delayed granulomatous reactions to facial cosmetic injections of polymethylmethacrylate microspheres and liquid injectable silicone: a case series. J cosmet laser Ther: Off Publ Eur Soc Laser Dermatol, 2016; 18(3): 170–173.
17. GOODMAN GJ e CLAGUE MD A Rethink on Hyaluronidase Injection, Intraarterial Injection, and Blindness: Is There Another Option for Treatment of Retinal Artery Embolism Caused by Intraarterial Injection of Hyaluronic Acid? Dermatol Surg, 2016; 42(4): 547-549.
18. HIRSCH RJ, et al. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg, 2007; 33: 357–360.
19. IBÁÑEZ-BERGANZA M, et al. Subjectivity and complexity of facial attractiveness. Sci Rep, 2019; 9: 8364.
20. JANG JW e KANG SY. Evaluation and management of facial granuloma caused by various injection materials. Arch Craniofac Surg, 2021; 22(1): 26-32.
21. JONES DH, et al. Preventing and Treating Adverse Events of Injectable Fillers: Evidence-Based Recommendations From the American Society for Dermatologic Surgery Multidisciplinary Task Force. Dermatol Surg, 2021; 47(2): 214-226.
22. KIM ZH, et al. A composite dermal filler comprising cross-linked hyaluronic acid and human collagen for tissue reconstruction. J Microbiol Biotechnol, 2015; 25(3): 399–406.
23. KURKJIAN TJ, et al. Soft-tissue fillers in rhinoplasty. Plast Reconstr Surg, 2014; 133(2): 121e-6e.
24. MCCRAKEN MS, et al. Hyaluronic acid gel (Restylane) filler for facial rhytides: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr Surg, 2006; 22(3): 188-191.
25. MOON HJ. Injection Rhinoplasty Using Filler. Facial Plast Surg Clin NorthAm, 2018; 26(3): 323-330.
26. MOON HJ. Use of Fillers in Rhinoplasty. Clin Plast Surg, 2016; 43(1): 307-317.
27. NEVES JC, et al. Rhinoplasty Dissection Planes (Subcutaneous, Sub-SMAS, Supra-perichondral, and Sub-perichondral) and Soft Tissues Management. Facial Plast Surg, 2021; 37(1): 2-11.
28. PARADA MB, et al. Fillers: Complications and Their Management. In: Issa, M., Tamura, B. (eds) Botulinum Toxins, Fillers and Related Substances. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, 2019, vol 4; 443p.
29. RAMOS HHA, et al. Hyaluronic acid filler in the treatment for drooping tip: anatomical concepts and clinical results. Aesthet Plast Surg, 2020; 44(6): 2173-2182.
30. RAMOS HHA, et al. Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic Acid. Aesthetic Plast Surg, 2021; 45(4): 1675-1682.
31. ROSEMAN CC e WEAVER TD. Multivariate apportionment of global human craniometric diversity. Am J Phys Anthropol, 2004; 125(3): 257–263.
32. ROSENBERGER ES e TORIUMI DM. Controversies in Revision Rhinoplasty. Facial Plast Surg Clin North Am, 2016; 24(3): 337-345.
33. ROUANET C, et al. Management of vascular complications following facial hyaluronic acid injection: high-dose hyaluronidase protocol: a technical note. J Stomatol Oral Maxillofac Surg, 2022; 123(2): 262–265.
34. SALINAS-ALVAREZ Y, et al. Hyaluronic Acid Embolism Treated with Subcutaneous High and Low Hyaluronidase Doses: Efficacy and Surrounding Tissue Effect. Plast Reconstr Surg, 2021;148(6):1281-1288.
35. SCIABICA S, et al. Design, Synthesis, Characterization, and In Vitro Evaluation of a New Cross-Linked Hyaluronic Acid for Pharmaceutical and Cosmetic Applications. Pharmaceutics. 2021; 13(10): 1672.
36. SITO G, et al. Vascular Complications after Facial Filler Injection: A Literature Review and Meta-analysis. J Clin Aesthet Dermatol, 2019; 12(6): E65-E72.
37. STAGLIANÒ S, et al. An Italian Online Survey Regarding the Use of Hyaluronidase in Previously Hyaluronic Acid-Injected Noses Looking for Surgical Rhinoplasty. Aesthet Surg J Open Forum, 2022; 4: ojac060.
38. THOMAS M e D’SILVA J. Nonsurgical Rhinoplasty. In: Keyhan SO, et al. Integrated Procedures in Facial Cosmetic Surgery. Springer, Cham. 2021; 235-248.
39. von BAHR G. Multiple embolisms in the fundus of an eye after an injection in the scalp. Acta Ophthalmol (Copenh), 1963; 41(1): 85-91.
40. WILKINS A. Making Faces: The Evolutionary Origins of the Human Face. The Belknap Press of Harvard University Press; 2017; 472p.